Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other Operating Expenses: 2017-2025

Historic Other Operating Expenses for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Jun 2025 value amounting to $3.5 million.

  • Rocket Pharmaceuticals' Other Operating Expenses was N/A to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$74.8 million, marking a year-over-year change of. This contributed to the annual value of -$78.2 million for FY2018, which is 118.81% down from last year.
  • Per Rocket Pharmaceuticals' latest filing, its Other Operating Expenses stood at $3.5 million for Q2 2025, which was up 347,200.00% from -$1,000 recorded in Q4 2020.
  • In the past 5 years, Rocket Pharmaceuticals' Other Operating Expenses ranged from a high of $3.5 million in Q2 2025 and a low of $3.5 million during Q2 2025.
  • Moreover, its 1-year median value for Other Operating Expenses was $3.5 million (2025), whereas its average is $3.5 million.